amikacin has been researched along with Burns in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (33.33) | 18.7374 |
1990's | 7 (19.44) | 18.2507 |
2000's | 7 (19.44) | 29.6817 |
2010's | 9 (25.00) | 24.3611 |
2020's | 1 (2.78) | 2.80 |
Authors | Studies |
---|---|
Asai, Y; Fujii, N; Maekawa, K; Mizuno, H; Mori, K; Sakawaki, E; Sawamoto, K; Tanno, K; Uemura, S; Yokota, S | 1 |
Alaghehbandan, R; Alinejad, F; Azimi, L; Lari, AR; Tahbaz, SV | 1 |
Javadi, A; Kazemian, H; Kodori, M; Monfared, MRZ; Rad, MR; Rahdar, H; Yazdani, F | 1 |
Allegaert, K; De Cock, P; Healy, DP; Kagan, RJ; Liu, X; Renard, M; Sherwin, CMT; Smits, A; Wang, Y; Wead, S | 1 |
Healy, D; Kagan, R; Neely, A; Sherwin, CM; Spigarelli, MG; Stockmann, C; Wead, S | 1 |
Aghazadeh, M; Hojabri, T; Hojabri, Z; Mahdian, R; Nahaei, MR; Pajand, O; Pirzadeh, T; Rahmati, M | 1 |
Debata, NK; Jena, J; Sahoo, RK; Subudhi, E | 1 |
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
Hua, R; Rong, XZ; Yang, RH; Zhang, T | 4 |
Akers, KS; Chung, KK; Cota, JM; Frei, CR; Mende, K; Murray, CK | 1 |
Aypak, C; Bayram, I; Bayram, Y; Parlak, M | 1 |
Malik, A; Shahid, M | 1 |
Breden, A; Chabanon, G; Coley, N; Conil, JM; Georges, B; Houin, G; Lavit, M; Saivin, S; Samii, K; Segonds, C; Seguin, T | 1 |
Hansen, KD; Meyer, RF | 1 |
Eve, MD; Settle, JA; Smith, JH | 1 |
Dornák, F; Königová, R | 1 |
Song, GD | 1 |
Harper, DJ; Hollingsed, TC; Jennings, JP; Morris, SE; Saffle, JR | 1 |
Botha, JH; Forsyth, NB; Hadley, GP | 1 |
Estahbanati, HK; Ghanaatpisheh, F; Kashani, PP | 1 |
Altemeier, WA; Hummel, RP; Miskell, PW | 1 |
Minshew, BH; Pollock, HM; Schoenknecht, FD; Sherris, JC | 1 |
Ceyrat, J; Flandrois, JP; Marichy, J | 1 |
Caniggia, M; Garabedian, M; Kiegel, P; Lombard, C; Manelli, JC; Palayret, D; Perez-Cappellano, R | 1 |
Sawchuk, RJ; Strate, RG; Zaske, DE | 1 |
Overturf, GD; Wilkins, J; Zawacki, BE | 1 |
Zhang, YP | 2 |
Fant, WK; Kopcha, RG; Warden, GD | 1 |
Rong, XZ | 1 |
Jia, CY | 1 |
Gary, LB; Hall, JW; Herndon, DN; Winkler, JB | 1 |
Besse, MD; Crépy, A; Galizia, JP; Goldstein, P; Marson, JC; Pellerin, P | 1 |
5 trial(s) available for amikacin and Burns
Article | Year |
---|---|
[Pharmacokinetics changes of amikacin in severe burn patients at early stage].
Topics: Adult; Amikacin; Burns; Female; Humans; Male; Serum | 2008 |
Increased amikacin dosage requirements in burn patients receiving a once-daily regimen.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Burns; Drug Administration Schedule; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Regression Analysis; Wound Infection | 2006 |
[Pharmacokinetics of amikacin in the subeschar tissue fluid following severe burns].
Topics: Adult; Amikacin; Anti-Bacterial Agents; Burns; Extracellular Space; Exudates and Transudates; Female; Humans; Infusions, Intravenous; Male; Skin | 2007 |
[Dynamic changes of blister fluid amikacin concentration after its early-stage administration in severely burned patients].
Topics: Adult; Amikacin; Anti-Bacterial Agents; Blister; Burns; Exudates and Transudates; Female; Humans; Infusions, Intravenous; Male; Young Adult | 2007 |
A comparison of two amikacin dosing regimens in paediatric surgical patients.
Topics: Amikacin; Anti-Bacterial Agents; Burns; Child; Child, Preschool; Female; Hearing Disorders; Humans; Infant; Kidney; Male; Treatment Outcome | 1997 |
31 other study(ies) available for amikacin and Burns
Article | Year |
---|---|
Acquisition of a transposon encoding extended-spectrum beta-lactamase SHV-12 by Pseudomonas aeruginosa isolates during the clinical course of a burn patient.
Topics: Adult; beta-Lactamases; Burns; DNA Transposable Elements; Female; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa | 2010 |
Synergistic Effect of Tazobactam on Amikacin MIC in Acinetobacter baumannii Isolated from Burn Patients in Tehran, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Burns; Drug Resistance, Multiple, Bacterial; Drug Synergism; Genes, Bacterial; Humans; Iran; Microbial Sensitivity Tests; Tazobactam | 2020 |
Antibacterial Activity of Gold Nanoparticles Conjugated by Aminoglycosides Against
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Burns; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gentamicins; Gold; Humans; Metal Nanoparticles; Microbial Sensitivity Tests; Patents as Topic; Wound Infection | 2018 |
Impact of Disease on Amikacin Pharmacokinetics and Dosing in Children.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Burns; Child; Child, Preschool; Female; Gram-Negative Bacterial Infections; Humans; Infant; Male; Neoplasms; Retrospective Studies | 2019 |
Amikacin population pharmacokinetics among paediatric burn patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Body Surface Area; Body Weight; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Multivariate Analysis; Regression Analysis; Sepsis; Vancomycin | 2014 |
Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Burns; Cephalosporinase; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2014 |
Phylogenetic study of metallo-β-lactamase producing multidrug resistant Pseudomonas aeruginosa isolates from burn patients.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Burns; Ceftazidime; Ceftriaxone; Cilastatin; Clavulanic Acid; Colistin; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Multiple, Bacterial; Genetic Variation; Humans; Imipenem; Minocycline; Netilmicin; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Pseudomonas aeruginosa; Tigecycline | 2015 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Burns; Exudates and Transudates; Female; Humans; Male; Middle Aged; Prospective Studies; Vancomycin; Young Adult | 2009 |
Once-daily amikacin dosing in burn patients treated with continuous venovenous hemofiltration.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Burns; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hemofiltration; Humans; Male; Middle Aged; Retrospective Studies | 2011 |
Three-year review of bacteriological profile and antibiogram of burn wound isolates in Van, Turkey.
Topics: Adult; Amikacin; Burns; Carbapenems; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infections; Male; Retrospective Studies; Turkey | 2013 |
Multidrug-resistant Pseudomonas aeruginosa strains harbouring R-plasmids and AmpC beta-lactamases isolated from hospitalised burn patients in a tertiary care hospital of North India.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; India; Inpatients; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; R Factors; Transformation, Bacterial | 2003 |
Amikacin treatment of Pseudomonas-caused corneal ulcer.
Topics: Adolescent; Adult; Amikacin; Burns; Child; Corneal Ulcer; Drug Resistance, Microbial; Eye Injuries; Humans; Kanamycin; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections | 1980 |
The use of aminoglycosides in a regional burn unit.
Topics: Adolescent; Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Burns; Child, Preschool; Humans; Kidney Function Tests; Middle Aged; Pseudomonas Infections | 1981 |
[Our experience with amikacin administration in severe burns].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Burns; Child; Child, Preschool; Female; Humans; Kanamycin; Male; Middle Aged | 1980 |
[Septicemia in early stage of severe burns].
Topics: Adult; Aged; Amikacin; Bacteremia; Burns; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Penicillins; Shock; Staphylococcal Infections; Time Factors | 1993 |
Aminoglycoside dosing in burn patients using first-dose pharmacokinetics.
Topics: Adult; Amikacin; Burns; Child; Child, Preschool; Gentamicins; Half-Life; Humans; Infant; Middle Aged | 1993 |
Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics.
Topics: Acinetobacter; Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Burns; Carbenicillin; Ceftazidime; Ceftizoxime; Cephalothin; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Female; Gentamicins; Humans; Infant; Male; Middle Aged; Pseudomonas aeruginosa; Serotyping; Staphylococcus aureus; Tetracycline; Wound Infection | 2002 |
Antibiotic resistance transfer from nonpathogenic to pathogenic bacteria.
Topics: Alcaligenes; Amikacin; Animals; Anti-Bacterial Agents; Burns; Drug Resistance, Microbial; Gentamicins; Germ-Free Life; Intestines; Mice; Mice, Inbred ICR; Pseudomonas aeruginosa; R Factors; Sisomicin; Tobramycin | 1977 |
Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Burns; Drug Resistance, Microbial; Escherichia coli; Gentamicins; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1977 |
[Pharmacokinetics of amikacin in burn patients (preliminary results)].
Topics: Adolescent; Adult; Amikacin; Burns; Humans; Kanamycin; Kinetics; Middle Aged | 1979 |
[Clinical and pharmacokinetic study of amikacin in septicemia complicating major burns].
Topics: Adolescent; Adult; Aged; Amikacin; Burns; Humans; Kanamycin; Kinetics; Microbial Sensitivity Tests; Middle Aged; Sepsis | 1979 |
The necessity of increased doses of amikacin in burn patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Burns; Creatinine; Half-Life; Humans; Infant; Kanamycin; Middle Aged | 1978 |
Emergence of resistance to amikacin during treatment of burn wounds: the role of antimicrobial susceptibility testing.
Topics: Adolescent; Adult; Aged; Amikacin; Burns; Child; Child, Preschool; Drug Resistance, Microbial; Humans; Kanamycin; Microbial Sensitivity Tests; Middle Aged; Providencia; R Factors; Wound Infection | 1976 |
[Common pathogens in burn infection and changes in their drug sensitivity].
Topics: Amikacin; Burns; Ciprofloxacin; Female; Humans; Male; Microbial Sensitivity Tests; Piperacillin; Proteus; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 1991 |
Increased dosing requirements for amikacin in burned children.
Topics: Adolescent; Age Factors; Amikacin; Burns; Child; Child, Preschool; Female; Humans; Infant; Male | 1991 |
[Experimental study of pulmonary infection and its systemic dissemination in the early stage of severe burn].
Topics: Amikacin; Animals; Burns; Disease Susceptibility; Endotoxins; Female; Male; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sepsis | 1990 |
[Drug resistance and floral distribution of Pseudomonas aeruginosa].
Topics: Amikacin; Burns; Ceftazidime; Cross Infection; Drug Resistance, Microbial; Female; Humans; Middle Aged; Norfloxacin; Pseudomonas aeruginosa; Serotyping | 1990 |
[Opportunistic infection and systemic dissemination in burns].
Topics: Amikacin; Burns; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Opportunistic Infections; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia | 1989 |
Auditory brainstem response in young burn-wound patients treated with ototoxic drugs.
Topics: Adolescent; Amikacin; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Audiometry, Evoked Response; Brain Stem; Burns; Child; Child, Preschool; Female; Gentamicins; Hearing Disorders; Humans; Infant; Male; Vancomycin | 1986 |
[The use of aminosides in the burn patient].
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Burns; Humans; Netilmicin; Tobramycin | 1986 |